NEXALIN TECHNOLOGY INC (NXL) Fundamental Analysis & Valuation

NASDAQ:NXL • US65345B2016

Current stock price

0.3519 USD
0 (-0.73%)
At close:
0.37 USD
+0.02 (+5.14%)
After Hours:

This NXL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NXL Profitability Analysis

1.1 Basic Checks

  • NXL had negative earnings in the past year.
  • In the past year NXL has reported a negative cash flow from operations.
  • NXL had negative earnings in each of the past 5 years.
  • In the past 5 years NXL always reported negative operating cash flow.
NXL Yearly Net Income VS EBIT VS OCF VS FCFNXL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • NXL's Return On Assets of -169.31% is on the low side compared to the rest of the industry. NXL is outperformed by 89.36% of its industry peers.
  • NXL has a Return On Equity of -182.01%. This is in the lower half of the industry: NXL underperforms 75.53% of its industry peers.
Industry RankSector Rank
ROA -169.31%
ROE -182.01%
ROIC N/A
ROA(3y)-110.33%
ROA(5y)-801.91%
ROE(3y)-127.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXL Yearly ROA, ROE, ROICNXL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

  • The Gross Margin of NXL (69.55%) is better than 78.19% of its industry peers.
  • In the last couple of years the Gross Margin of NXL has grown nicely.
  • The Profit Margin and Operating Margin are not available for NXL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.73%
GM growth 5Y2.21%
NXL Yearly Profit, Operating, Gross MarginsNXL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NXL Health Analysis

2.1 Basic Checks

  • NXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NXL Yearly Shares OutstandingNXL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NXL Yearly Total Debt VS Total AssetsNXL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • NXL has an Altman-Z score of -18.33. This is a bad value and indicates that NXL is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -18.33, NXL is doing worse than 88.83% of the companies in the same industry.
  • NXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -18.33
ROIC/WACCN/A
WACC8.99%
NXL Yearly LT Debt VS Equity VS FCFNXL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

  • NXL has a Current Ratio of 13.48. This indicates that NXL is financially healthy and has no problem in meeting its short term obligations.
  • NXL has a Current ratio of 13.48. This is amongst the best in the industry. NXL outperforms 97.87% of its industry peers.
  • NXL has a Quick Ratio of 13.03. This indicates that NXL is financially healthy and has no problem in meeting its short term obligations.
  • NXL's Quick ratio of 13.03 is amongst the best of the industry. NXL outperforms 97.87% of its industry peers.
Industry RankSector Rank
Current Ratio 13.48
Quick Ratio 13.03
NXL Yearly Current Assets VS Current LiabilitesNXL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. NXL Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%537.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y22.31%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year185.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXL Yearly Revenue VS EstimatesNXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200K 400K 600K 800K 1M
NXL Yearly EPS VS EstimatesNXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. NXL Valuation Analysis

4.1 Price/Earnings Ratio

  • NXL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXL Price Earnings VS Forward Price EarningsNXL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXL Per share dataNXL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NXL Dividend Analysis

5.1 Amount

  • No dividends for NXL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NXL Fundamentals: All Metrics, Ratios and Statistics

NEXALIN TECHNOLOGY INC

NASDAQ:NXL (4/2/2026, 8:00:02 PM)

After market: 0.37 +0.02 (+5.14%)

0.3519

0 (-0.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-25
Earnings (Next)05-11
Inst Owners6.62%
Inst Owner Change0%
Ins Owners12.78%
Ins Owner Change0%
Market Cap6.56M
Revenue(TTM)N/A
Net Income(TTM)-8.68M
Analysts80
Price Target4.08 (1059.42%)
Short Float %2.74%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.01%
Min EPS beat(2)-7.26%
Max EPS beat(2)29.28%
EPS beat(4)1
Avg EPS beat(4)-39.38%
Min EPS beat(4)-131.02%
Max EPS beat(4)29.28%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)21.47%
Min Revenue beat(2)-55.07%
Max Revenue beat(2)98.02%
Revenue beat(4)2
Avg Revenue beat(4)12.01%
Min Revenue beat(4)-55.07%
Max Revenue beat(4)98.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 41.8
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB 1.47
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.01
BVpS0.26
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -169.31%
ROE -182.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.55%
FCFM N/A
ROA(3y)-110.33%
ROA(5y)-801.91%
ROE(3y)-127.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.73%
GM growth 5Y2.21%
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.42%
Cap/Sales 11.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.48
Quick Ratio 13.03
Altman-Z -18.33
F-Score2
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.64%
EPS Next Y22.31%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%537.04%
Revenue Next Year185.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.27%
OCF growth 3YN/A
OCF growth 5YN/A

NEXALIN TECHNOLOGY INC / NXL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEXALIN TECHNOLOGY INC?

ChartMill assigns a fundamental rating of 2 / 10 to NXL.


Can you provide the valuation status for NEXALIN TECHNOLOGY INC?

ChartMill assigns a valuation rating of 0 / 10 to NEXALIN TECHNOLOGY INC (NXL). This can be considered as Overvalued.


Can you provide the profitability details for NEXALIN TECHNOLOGY INC?

NEXALIN TECHNOLOGY INC (NXL) has a profitability rating of 1 / 10.


What is the financial health of NEXALIN TECHNOLOGY INC (NXL) stock?

The financial health rating of NEXALIN TECHNOLOGY INC (NXL) is 7 / 10.